0000874015-23-000176.txt : 20230719
0000874015-23-000176.hdr.sgml : 20230719
20230719180555
ACCESSION NUMBER: 0000874015-23-000176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLEIN JOSEPH III
CENTRAL INDEX KEY: 0001206369
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 231097706
MAIL ADDRESS:
STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC
STREET 2: FIVE SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-07-17
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001206369
KLEIN JOSEPH III
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
0
Common Stock
2023-07-17
4
M
0
1777
0.0
A
18568
D
Common Stock
2023-07-17
4
M
0
5333
0.0
A
23901
D
Common Stock
2023-07-18
4
S
0
3555
42.0
D
20346
D
Common Stock
100
I
by Son
Common Stock
6000
I
by Trust
Restricted Stock Unit
0.0
2023-07-17
4
M
0
1777
0.0
D
Common Stock
1777
10010
D
Restricted Stock Unit
0.0
2023-07-17
4
M
0
5333
0.0
D
Common Stock
5333
4677
D
Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 17, 2022
The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
By: Patrick R. O'Neil, attorney-in-fact For: Joseph Klein III
2023-07-19